Abstract
Approximately one third of gastroesophageal reflux disease (GERD) patients are resistant or partially responsive to proton pump inhibitors (PPIs). It is assumed that non-acid reflux is the cause of 15–62% of cases concerning the PPI therapy inefficacy in GERD patients. The review reveals the issues on the prevention and therapy of non-acid GERD types, ways to improve the treatment efficacy. Understanding the patterns of reflux and pathogenetic mechanisms of non-acid GERD types makes it possible to choose the right drugs. For the prevention and treatment of bile reflux, it is necessary to normalize esophageal, gastric and duodenal motility, as well as biliary system function, and prescribe adequate antisecretory and cytoprotective therapy. The basic drugs for the GERD treatment are PPIs. In order to elevate the GERD therapy effect, drugs are used that can enhance the protective factors of the mucous membranes, i.e., cytoprotectors. UDCA drugs are the basis of GERD therapy with a predominance of bile reflux. Prokinetics are used in the treatment of duodenogastroesophageal reflux to normalize the biliary system function, as well as the motor-evacuation function of the stomach and intestines. Heterogeneity of pathogenesis, including the possibility of acid and non-acid gastroesophageal reflux, necessitates GERD differentiated therapy. KEYWORDS: GERD, reflux, prokinetic, gastroprotectors, cytoprotector, proton pump inhibitors. FOR CITATION: Seliverstov P.V., Lazareva Yu.A., Egorov D.V. Methods for GERD therapy according to its clinical form diversity. Russian Medical Inquiry. 2023;7(7):432–438 (in Russ.). DOI: 10.32364/2587-6821-2023-7-7-5.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.